ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.

Bourdin, A; Bjermer, L; Brightling, C; Brusselle, G; Chanez, P; Chung, F; Custovic, A; Diamant, Z; Diver, S; Djukanovic, R; Hamerlijnck, D; Johnston, S; Kanniess, F; Papadopoulos, N; Papi, A; Russell, R; Ryan, D; Samitas, K; Thomy, T; Zervas, E; ... (2019). ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions. European respiratory journal, 54(3), p. 1900900. European Respiratory Society 10.1183/13993003.00900-2019

Preview	Text Bourdin EurRespirJ 2019_postprint.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview
	Text Bourdin EurRespirJ 2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (857kB)

Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent a serious outcome such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial huge healthcare costs, and psychological burden including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a Task Force (TF) to search for a clear definition of severe exacerbations and to also define research questions and priorities. The statement includes comments from patients who were members of the TF.

Interest & Impact

Downloads

108 since deposited on 09 Sep 2019
23 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item